W2O Acquires Symplur to Innovate, Scale and Increase Accessibility to Its Proprietary Healthcare Data and Insights Platform

 — Immediately Enhances Ability to Precisely Listen, Target and Engage with Key Influencers, Customers and Stakeholders —

— Firms Currently Collaborating to Track Critical COVID-19 Conversations —

SAN FRANCISCO–W2O, the leading independent provider of analytics-driven, digital-first marketing communications to the healthcare sector, today announced the acquisition of Symplur, a social media analytics platform exclusively focused on the healthcare sector.

Symplur provides an easy-to-use interface and analytical capabilities that will help make W2O’s data and analytics operating system and technology accessible to a broader range of non-technical users. In the future, W2O will add new features and products to the platform that will further be informed by and benefit its wide range of healthcare clients.

Symplur’s proprietary, purpose-built social media analytics platform – the only tool of its kind on the market designed entirely for healthcare – allows for the rapid and easy identification of social media trends among physicians, patient advocates, life science professionals, media and other key audiences of interest to healthcare organizations, government entities and academic institutions. Through a collaboration with the California Life Sciences Association, W2O and Symplur are already utilizing the platform in conjunction with W2O’s proprietary data and technology stack to track COVID-19-specific conversations and trends across the healthcare ecosystem.

“Particularly in these challenging, uncertain times reverberating across global communities and economies, healthcare companies are looking to track essential information in an urgent and immediate manner utilizing data and analytics to discern insights for decision-making,” said W2O Founder and CEO Jim Weiss. “Symplur’s pioneering technology products turn up the volume on the most important, and often overlooked, voices in healthcare, ultimately engineering a path to a deeper understanding of this dynamic, complex sector. Symplur is another in a series of strategic investments in people, technology and platforms that we’ve made, and intend to make, to strengthen the solutions we provide to clients. W2O now has hundreds of people focused in technology, data science, audience analytics, activation and measurement and we will double down in this space going forward.”

The acquisition is designed to expand W2O’s proprietary data and technology platform and corresponding solutions, further enabling the firm to focus on combining data-rich intelligence with technology to solve clients’ problems in real-time, successfully communicate and market their product offerings, and drive overall value for their brands.

“Insights derived from social media analytics are significantly impacting the entire healthcare ecosystem. Our massive Healthcare Social Graph® platform, which uses machine learning, enables us to extract the most valuable insights to meet the needs of a diverse range of healthcare clients and ultimately drive their priorities forward,” said Audun Utengen, Symplur co-founder and CEO. “This work over many years has helped us expedite the development of relevant, powerful technology platforms like those used to help track critical COVID-19 conversations from authentic, expert sources.”

Symplur’s technology and intelligence reports are currently utilized by pharmaceutical companies and government agencies, including the National Institutes of Health (NIH) and the National Institute of Allergy and Infectious Diseases (NIAID).

Symplur and W2O are privately held companies, and the financial terms of the acquisitions are not being disclosed. This acquisition, which was completed in partnership with W2O’s private equity partner, New Mountain Capital, marks the firm’s fifth acquisition in nine months. Symplur, which will now operate as W2O symplur, adds a team of seasoned software architects and developers to the W2O family. Symplur co-founders Utengen and Thomas Lee will continue to serve in leadership roles and be key participants in the development of the firm’s audience planning product suite.

“Audun, Thomas and their highly adept team will strengthen our audience planning, intelligence and engagement capabilities while helping enrich our data taxonomy and making our technology platform and offerings more robust, automated, faster and easier to use,” added Adam Cossman, W2O’s Group President and Managing Partner, Technology Products & Solutions. “We look forward to developing additional end-to-end integrated marketing communications tools fueled by technology, taking what we already do for clients and increasingly automating it – turning our services into technology-driven solutions for which our clients are clamoring. To that end, we continue to look for innovative companies and technology that can enrich our offering in these critical areas.”

About Symplur

Headquartered in Pasadena, Calif., Symplur’s unmatched social media analytics platform tracks how physicians and other healthcare stakeholders produce and consume medical information online, which increasingly appears in free, open-access environments such as Twitter. Its proprietary Healthcare Social Graph®, the world’s largest database of its kind, comprises over tens of thousands of healthcare topics with billions of conversations around any given therapeutic area among millions of influencers in real-time. This unique platform empowers users to learn from the expertise shared publicly by patients, clinicians and other relevant stakeholders. Symplur’s additional solutions-oriented capabilities include influencer analyses, which utilize proprietary recursive algorithms to accurately identify the true influencers in any given healthcare topic; stakeholder segmentation, which identifies and categorizes the people behind the conversations; classification, which combines human curation and automated processes to organize, structure and appropriately categorize raw social data; and engagement analyses, which measure levels of engagement to determine what is resonating and driving conversations.

About W2O 

Founded by Jim Weiss in 2001, W2O seeks to make the world a healthier place through marketing communications. The Company applies proprietary analytics models, methodologies and approaches in a digital world to design precise communications and marketing strategies to deliver sustained business and organizational results. W2O maintains 15 offices across the United States and in Europe.

For more information, please visit www.w2ogroup.com.

Follow W2O on Twitter  
Follow W2O on LinkedIn  
Follow W2O on Facebook

Contacts

Peter Duckler, 310-774-3425 
pduckler@w2ogroup.com

Symplur

Symplur - @symplur

Symplur creates products purpose-built for healthcare to make the move from insight to action as simple as possible.